Chronic kidney disease (CKD) is a global health concern, and the limited treatment options for end-stage kidney disease have remained unchanged for decades. Concurrent insults to the kidney can exacerbate disease progression, but...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
MetaboKID
Dissecting renal metabolic reprogramming heterogeneity to ta...
Cerrado
PID2019-104233RB-I00
REPROGRAMACION METABOLICA PARA COMBATIR LA FIBROSIS RENAL
428K€
Cerrado
SAF2015-66107-R
IDENTIFICACION DE LOS MICRORNAS IMPLICADOS EN LAS BASES META...
448K€
Cerrado
SAF2017-89782-R
COMO MODELAR LA NEFROPATIA DIABETICA: RESTABLECIENDO EL EPIG...
182K€
Cerrado
ROAR
Role of endocycle in Acute Kidney Injury Response and Chroni...
171K€
Cerrado
RTI2018-099946-B-I00
APLICACION DE TUBULOS BIOARTIFICIALES AL ESTUDIO DE LA INICI...
97K€
Cerrado
Información proyecto SPARK
Duración del proyecto: 59 meses
Fecha Inicio: 2025-01-01
Fecha Fin: 2029-12-31
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Chronic kidney disease (CKD) is a global health concern, and the limited treatment options for end-stage kidney disease have remained unchanged for decades. Concurrent insults to the kidney can exacerbate disease progression, but the underlying potential to have kidney repair after such injury remains poorly understood. The tricarboxylic acid (TCA) cycle, a fundamental metabolic pathway, plays a vital role in energy production and biomolecule synthesis. Recent research by my group has revealed that failed repair and subsequent fibrosis in kidney epithelial cells are linked to anaplerotic failure in the TCA cycle, resulting in the inability to maintain sufficient levels of TCA intermediates. These metabolites regulate chromatin remodeling and cell signaling pathways, influencing cell fate decisions. SPARK aims to investigate the impact of perturbed cell metabolism and metabolic crosstalk within kidney microenvironments on cell fate decisions during injury and repair. The project will map the metabolic, proteomic, and transcriptomic interactome at an unprecedented resolution, focusing on the kidney tissue microenvironment. By integrating spatial multi-omics data, exometabolite interactome analysis, and human kidney biopsies, actionable targets will be identified. In vivo studies using reporter mice and ex vivo preserved human kidneys will validate the metabolic effects of the selected targets. This research will provide insights into how the metabolic interactome governs repair through epigenetic modulations in the kidney and establish a paradigm for studying tissue homeostasis in various contexts.